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Abstract 
While the private sector is an important health care provider in many low and middle income 
countries (LMICs), its role in relation to progress towards Universal Health Coverage (UHC) varies.  
Drawing on a review of the published and grey literature, we explore the factors that affect private 
sector contribution to UHC: i.e. we are interested in the overall impact on system outcomes such as 
ƚŚĞƉŽƉƵůĂƚŝŽŶ ?ƐĂĐĐĞƐƐƚŽƐĞƌǀŝĐĞƐĂŶĚĞƋƵŝƚǇ. Evidence on the performance of both the private and 
public healthcare sectors is used to examine the characteristics of private providers that are 
associated with their performance, and the implications for how these factors might interrelate to 
influence progress towards UHC. Studies of private sector performance have focused on three main 
dimensions: quality, equity of access, and efficiency. We found that the characteristics of patients, 
the structures of both the public and private sectors, and the regulation of the sector influence the 
types of health services delivered, and outcomes. Combined with characteristics of private providers 
 ? including their size, objectives, and technical competence  ? the interaction of these factors 
influences how the sector performs within different contexts. Changing the performance of the 
private sector will require interventions which target the sector as a whole, rather than individual 
providers alone. In particular, the performance of the private sector appears to be intrinsically linked 
to the structure and performance of the public sector, which suggests that deriving population 
benefit from the private health sector requires a regulatory response focused on the health sector as 
a whole.  
Key messages 
x The critical policy relevant question about the private sector is not its performance in isolation, 
or relative to the public sector, but the extent to which it supports or detracts from progress 
towards Universal Health Coverage 
x There is a dearth of evidence on factors affecting system level performance, reflecting the 
complexity and heterogeneity of the private health sector and the difficulty in exploring the 
inter-relationships of factors at the system level, and their effect on overall performance. 
x Deriving population benefit from the private health sector will require interventions which 
target the sector as a whole, rather than individual providers alone. 
Key words: private health provider; performance; health system; quality; equity; efficiency 
Introduction 
While the private sector is an important source of health care provision in many low and middle 
income countries (LMICs), its role varies widely across countries (1). The heterogeneity and 
complexity of the sector make any judgement about performance complex and nuanced (2). Despite 
these difficulties, a number of studies have attempted to assess private sector performance  ? usually 
through comparisons with the public sector (3, 4). Most focus on specific types of private providers 
and discuss factors which influence provŝĚĞƌƐ ?performance, but overall conclusion regarding such 
factors is challenging. Most such studies include a small sample or narrow range of providers, but 
individual performance ranges widely and depends substantially on the context in which providers 
are operating. Furthermore, a narrow focus on individual performance rather than on the overall 
impact of a particular provider on the health care opportunities for relevant populations misses 
what may be the most important implications of a changing public-private mix. Private providers 
may individually provide excellent quality, but if they absorb a disproportionate share of the health 
workforce and are inaccessible to a majority of the population, their overall contribution may still be 
assessed as negative; alternatively they might train high quality health staff who are later employed 
in more accessible public provision systems. It is these chains of inter-relationships between private 
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sector behaviour and population health outcomes that shape the implications for Universal Health 
Coverage (UHC).  
This suggests that whether the private or public sector performs best is a sterile question. An 
assessment on the contribution of any single provider depends on its system level impact, including 
whether it fills gaps left by other providers or creates new ones. Such a contribution is premised on a 
host of economic and social factors. A dearth of research at this system level is an indication of the 
complexities inherent in attempting to explore these relationships.  
This paper seeks to review the evidence surveying important individual factors, which are well-
researched but may be misleading because they are presented in isolation of context, and consider 
implications for UHC. The paper is structured as follows: the next section describes the literature 
search strategy, followed by a presentation of available evidence on the performance of the private 
sector in relation to quality, efficiency, and equity. The characteristics of individual private provider 
types that are considered to be associated with performance are then discussed. We then develop a 
conceptual framework theorising the linkages between individual performance characteristics and 
system-level impacts that determine progress towards UHC (illustrated in figure one). By identifying 
factors which affect private sector performance as a whole, we aim to stimulate a debate on how 
overall private sector performance affects system-level outcomes, and the types of interventions 
that can be implemented to support UHC. 
Search strategy  
Drawing on a review of the published and grey literature, this paper investigated and searched for 
studies which explored private health sector performance in relation to quality, equity, and 
efficiency. As discussed in the introduction, most studies have explored the performance of specific 
types of private providers. The lack of research on system-level influences and impacts meant that 
these factors had to be extrapolated from these studies. Only studies that reported performance 
outcomes or included an assessment of factors that determine performance are included.  
  
Both qualitative and quantitative studies are included. PubMed and EBM Reviews were used for 
published literature, supplemented by Google Scholar for Grey literature. Search terms were 
designed to capture the diversity of the private sector. A combination of the following terms was 
ƵƐĞĚ ? ‘ƉƌŝǀĂƚĞƐĞĐƚŽƌ ?KZ ‘ƉƌŝǀĂƚĞƉƌŽǀŝĚĞƌ ?KZ ‘ƉƌŝǀĂƚĞ ĂĐƚŝƚŝŽŶĞƌ ?EƌŽůĞKZƉĞƌĨŽƌŵĂŶĐĞE
quality OR efficiency OR equity AND  ‘ĚĞǀĞůŽƉŝŶŐĐŽƵŶƚƌǇ ?KZ ‘ůŽǁĂŶĚŵŝĚĚůĞŝŶĐŽŵĞĐŽƵŶƚƌǇ ? ? 
Reference lists were also searched in order to look for additional relevant literature. The titles and 
abstracts of peer-reviewed articles and grey literature were reviewed. Overall, 51 peer-reviewed 
articles, along with grey literature, which focused on the performance of private health care 
providers in relation to quality, efficiency, or equity are included. 
 
Performance of the Private Health Sector: Quality, Equity & Efficiency  
Three general outcome measures are used in order to assess the performance of the private health 
sector: quality, equity and efficiency. These terms were selected because they are widely used and 
encompass many other terms, such as responsiveness and access. Despite the heterogeneous nature 
of the private sector, we found that many studies fail to be clear about the type of private provider 
when reporting on performance, instead grouping all providers together. As a result, some 
performance assessments apply to only one or two types of providers, even though results are 
presented as applying to the sector as a whole.  
4 
 
Quality 
Quality has two main components: service quality, including responsiveness of staff and often 
measured by patient satisfaction; and technical quality, incorporating the competence of providers 
and their adherence to clinical guidelines (4). Many comparative studies suggest that when 
compared to the public sector, service quality is better in the private sector. Comparing health care 
for female outpatients in south-central India, for example, Bhatia and Cleland (5: 408) found that 
 ?ƉƌŝǀĂƚĞƉƌĂĐƚŝƚŝŽŶĞƌƐĂƌĞƉƌŽǀŝĚŝŶŐĂďĞƚƚĞƌƐĞƌǀŝĐĞ ?ĚĞĨŝŶĞĚŝŶƌĞůĂƚŝŽŶƚŽĐŽŶƐƵůƚĂƚŝŽŶƚŝŵĞ ?ƉƌŝǀĂĐǇ ?
and likelihood of receiving information about diagnosis and prognosis, than their public sector 
ĐŽƵŶƚĞƌƉĂƌƚƐ ?. Likewise, a systematic review comparing the performance of private and public 
healthcare systems in LMICs found that clients thought private provider service delivery was better 
as a result of shorter waiting times, better hospitality, increased time spent with doctors, cleanliness 
of facilities, longer and flexible opening times, and better availability of staff (3).  
In contrast, there is evidence to suggest that technical quality across a range of private providers is 
inferior to the public sector, although many studies note that public sector services are also of a low 
standard. Basu et al. (3), for example, found that diagnostic accuracy, adherence to medical 
management standards or prescription guidelines, knowledge of correct diagnosis and treatment, 
and the incidence of unnecessary procedures, such as caesarean sections, were inferior in the 
private sector compared to the public sector in Nigeria, Uganda, South Africa, Vietnam, Laos, Peru, 
and Mexico. Likewise, studies in Zimbabwe and Uganda have found that many private providers 
have limited diagnostic capacity and erratic prescribing practices for HIV/AIDS (1, 6, 7); and in Nigeria 
and Vietnam poor adherence to prescription guidelines by private providers has been associated 
with a rise in drug-resistant Malaria (8, 9). 
Many of the studies in this area rely on users reporting on the provider used, and private providers 
are frequently lumped into one category, masking any differences between types and context of 
provision. Few studies disaggregate contexts and patient groups served; where they do, different 
results may be observed. The sub-Saharan African studies in particular use DHS evidence that largely 
reflects utilisation of unregulated, small private providers in contexts where the public sector is 
weak. In settings with a stronger public sector, and a complementary and better-regulated private 
sector, different comparisons emerge (10). In Sri Lanka, where the private sector complements a 
strong public sector, a study of private primary practitioners found that their quality was comparable 
to that of Australian doctors in relation to the clinical management of conditions (11). A recent study 
in Sri Lanka found evidence of similar quality in public and private hospitals (12). 
As discussed above, studies that explore quality within one or two types of provider fail to account 
for their contribution to overall health system performance. However, when broader structural 
factors  ? such as the nature of the public sector and effective regulatory practices  ? are considered, 
a picture of private sector performance affecting the system as a whole begins to emerge. 
Equity of Access 
We define equity as the fair availability of and access to quality health care commensurate with 
need and without regressive financial implications (3). Individually, private providers financed from 
individual out-of-pocket payments tend to exclude poorer patients and so might be considered 
inequitable. From a systems perspective, the more fundamental question is how they contribute to 
opportunities for health care access of the whole population, which impacts overall health system 
fairness and progress towards UHC. 
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Much of the literature focuses on the direct influence of private providers on equitable access. 
The majority of private services in LMICs are funded directly by patients (out-of-pocket). This feature 
itself tends to mean that private services from providers with qualified medical staff are likely to 
serve populations that are more affluent (3). For example, comparative analysis of DHS surveys, 
conducted in 27 countries between 1990 and 2004, clearly show that wealthier households 
disproportionately use private providers for child health services (10). DHS surveys suggest that the 
absolute levels of private sector use vary by geographic region but a gradient in utilization by 
socioeconomic status is apparent across all geographic regions (East Asia Pacific region, Latin 
America and Caribbean region, and the Middle East and North Africa), with the wealthy more likely 
to use private providers.  
Where there are gaps in public sector provision of essential services the poor may use some types of 
private providers disproportionately. In such instances, services are often of low quality and 
delivered by unqualified providers, but are accessible. According to Bloom et al. (13), the informal 
sector provides the majority of health care for the poor in many LMICs. Prata et al. (14) found, for 
example, that in 19 of 22 LMICs both the wealthy and the poor received more care from the private 
sector than from the public sector  ? when private providers are classified to include informal 
providers such as private drug shops. The convenience, accessibility, and affordability of these small 
private providers compared to public sector alternatives make them attractive to patients (15). Lack 
of effective regulation however, exposes poor patients to inadequately qualified practitioners 
providing low quality care in many settings (16).  
Efficiency  
Efficiency is the extent to which resources are used effectively or are wasted (17). Examples of 
inefficiencies include over-prescribing, wastage of stock, and use of branded rather than generic 
medicines. From the perspective of UHC, we are interested in the extent to which the presence of 
private providers impacts on overall efficiency, and hence on the extent to which a given level of 
health expenditure can cover a population with a range of services. A number of studies, focusing on 
the treatment of specific conditions, suggest that private treatment results in higher service costs, 
and thus potential inefficiency (3, 5, 18, 19). Higher rates of potentially unnecessary and expensive 
procedures, such as caesarean sections, are one source of higher costs (18). Much of the evidence, 
particularly derived from sample surveys, focuses on small, and often unqualified, private providers 
operating within a weak public health system and regulatory framework. In these circumstances it is 
unsurprising that the literature suggests that services are inefficient. For a similar clinical diagnosis, 
for example, average prescription drug costs in the private sector were found to be higher than in 
the public sector in countries such as India, Tanzania, and Bangladesh, where public services are 
poorly resourced and regulation is weak (3, 5, 19). In these circumstances consumers have no clear 
benchmarks of quality and are largely at the mercy of private prescribing. Delays in diagnosis caused 
by a lack of linkage between sectors is a further contribution to higher prices faced by service users. 
Basu ĞƚĂů ? ?Ɛ (3) systematic review, for example, found evidence that an absence of referral linkage 
between sectors and levels of the same sector mean that diagnostic investigations must often be 
repeated following referral since information is not passed between providers, resulting in higher 
costs and lower efficiency.  
Across all three outcome variables: quality, equity and efficiency, the performance of individual 
private providers is mixed. In LMIC contexts private providers have been found at both ends of the 
quality spectrum. Quality differs between low-qualified unregulated providers and well-qualified 
better-regulated providers, but not only according to this distinction. Private providers were often 
more accessible than public providers but there is a clear gradient in utilization by socioeconomic 
status  ? with the wealthy more likely to use expensive, high quality, qualified providers, and the 
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poor more likely to use less expensive, low-quality, unqualified providers. Private providers were 
also found to exhibit certain efficiency problems, particularly in relation to prescription costs and 
repeated diagnostic investigations; but the structure and type of private providers is again 
important, as much of the evidence focused on small, unqualified private providers operating within 
weak public health systems and regulatory frameworks. 
The following sections explore both individual and system-level factors which were found to 
influence the mixed private sector performance discussed above. These sections contribute to the 
aim of the review, to identify system level impacts of private participation, which are addressed in 
the final section.  
Provider Characteristics Affecting Performance 
The literature suggests that three groups of individual features appear to be important in driving the 
performance of individual providers: organisational objectives, competence of staff, and size of 
organisation.  
Organisational Objectives 
Organisational objectives of private providers vary. Providers are typically divided into For-Profit and 
Not-For Profit but this categorisation masks a more complex spectrum of provider objectives. These 
range from providers that focus largely on repayment of creditors or shareholder dividends, aiming 
to maximise financial gain to providers with a mandate to protect the health of a given population 
(20, 21). The evidence comparing for-profit and not-for profit private providers is mixed. Two studies 
have suggested that decentralised decision-making combined with organisational objectives 
common to not-for profit providers, enable them to deliver superior services compared to for-profit 
providers, even though the qualifications of practitioners are often lower than in for-profit private 
organisations (22, 23). A systematic review by Berendes et al. (4), which explored the quality of 
private and public ambulatory healthcare in LMICs, found little difference between for-profit and 
not-for profit private providers overall. However, not-for profit providers were found to do better 
than for-profit providers in relation to structural quality (building equipment, material, drug 
availability) and quality of delivery (responsiveness, but not patient satisfaction). The findings for 
technical quality were mixed. Both for-profit and not-for profit private providers were found to 
perform worse than the public sector in relation to competence while clinical practice was found to 
be superior within for-profit private providers.  
Further evidence is needed to show the link between the organisational objectives of for-profit and 
not-for profit private providers and quality, efficiency and equity outcomes, and how this effects 
performance of a health system as a whole. 
Competence of Staff  
The study by Berendes et al. (4) showed slightly lower competence of staff (defined as professional 
knowledge and skills, assessed using case scenarios or vignettes, provider interviews, or a formal 
test, and related to overall technical quality) within the private sector compared to the public sector, 
although the types of facilities compared are not always clear from the studies. A series of studies in 
India, Indonesia, Paraguay, and Tanzania focused on the clinical quality of individual practitioners 
working within the public and private sectors using competence measurements (24). These studies, 
which match like-with-like facilities, suggest that the competence of qualified doctors (defined as 
what doctors know and collected using vignettes, direct observation, and exit surveys) in the private 
sector was as good as or exceeded their colleagues in the public sector. This is perhaps unsurprising 
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given that they are often the same doctors with dual roles (25, 26) (a practice which has an effect on 
system level outcomes).  
The studies suggest that at the mid-ƌĂŶŐĞŽĨĐŽŵƉĞƚĞŶĐĞ ?ƉƌŝǀĂƚĞĚŽĐƚŽƌƐĂƌĞ ‘ĂƐŬŝŶŐŵŽƌĞƋƵĞƐƚŝŽŶƐ
ĂŶĚĚŽŵŽƌĞĞǆĂŵŝŶĂƚŝŽŶƐ ?ƚŚĂŶƐŝŵŝůĂƌƉƵďůŝĐƐĞĐƚŽƌƉƌŽǀŝĚĞƌƐ, which, depending on the complexity 
of the health issue, can lead to different efficiency, equity, and quality outcomes (24). In particular, 
the higher effort expended by private providers may lead to better outcomes for patients who 
present with ambiguous symptoms where diagnosis is complex. In India, for example, it was found 
that while public doctors may have insufficient time to understand complex symptoms and interpret 
multiple tests, the extra effort put in by private providers can lead to better outcomes (25). In 
contrast, where illness is relatively simple to diagnose or the illness is self-limiting, the additional 
effort by private providers may simply manifest in excessive treatment and prescribing. For these 
illnesses, the public sector is a more cost-effective provider. A similar conclusion is reached by an 
Indonesian study where public providers were found to offer the most effective preventive services, 
including antenatal care, while private doctors provided higher quality curative services, as 
measured by observation-based clinical management scores (26). In contrast, private facilities that 
depend heavily on nurses and midwives on average scored poorly for clinical management possibly 
because staff were required to extend their remit beyond their qualifications (24).  
Size of Organisations 
The size of organisations was found to influence provider performance. Larger facilities are able to 
share expensive cost items across a larger number of patients, provide larger volumes of similar 
cases to improve staff expertise, and ensure that a wide range of skills is available at all times. 
Operating at larger scale also supports the opportunity for health professionals to hone skills for 
providing increasingly rarely required services, and can therefore be a pre-requisite for quality care 
for such services (27). A much quoted review based on evidence in high-income countries suggested 
that the optimal size for an acute district hospital is around 200-400 beds (28) while a recent analysis 
of country hospitals in China suggested a range of between 200 and 600 beds (29). This rather crude 
generalisation is conditioned strongly by the way services are provided  ? a high day-case load may 
enable greater output from smaller inpatient capacity  ? and a wider range of services offered. It may 
also depend on the proximity to other facilities since a smaller facility may be efficient if it can rely 
on rapid referral to larger facilities in the case of complications. A recent study of the costs of 
surgery in India, for example, found the lowest costs in departments with high caseloads regardless 
of whether ownership was public, charitable or private (30). Data on hospital bed size are patchy and 
ĚŝĨĨŝĐƵůƚƚŽĐŽŵƉĂƌĞŐŝǀĞŶƐŚŝĨƚŝŶŐĚĞĨŝŶŝƚŝŽŶƐŽĨƚŚĞƚĞƌŵ ‘ŚŽƐƉŝƚĂů ?, but consistently show low 
hospital bed numbers in private hospitals (for example Kutty (31)) find average bed sizes of 26 and 
34 in private hospitals in Kerala in 1986 and 1995 respectively; and a study of hospitals in 
Guangdong province in China found that private for-profit hospitals had an average of 66 beds 
compared to 256 in the public sector (32). 
 
Health system level factors affecting private sector performance 
Moving beyond the individual provider level, the literature suggests that a series of health system 
factors impact the functioning of the private sector as a whole: the structure and performance of the 
public health sector, the structure of the private sector, the characteristics of patient demand for 
health care, and the regulation of the private health sector. Factors at the individual level are then 
linked to these system factors. The discussion is limited to factors that can be considered directly 
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part of the health system rather than broader societal influences such as economic, social and 
cultural factors, or overall level of development. 
Structure and Performance of the Public & Private Sectors 
The close links between public and private health sectors mean that they are likely to affect each 
ŽƚŚĞƌ ?Ɛperformance and structure. Poor performance and lack of availability of the public sector, for 
example, create gaps in service provision which the private sector steps in to fill, often providing 
essential primary services to the population. This gap may be the result of low public health 
expenditure, or low efficiency of public expenditure, leading to lack of capacity to provide services. 
In Bangladesh a shortage of qualified healthcare professionals in rural areas has long been 
acknowledged as a key reason why a larger part of the population seeks assistance from unqualified 
allopathic providers (33). In Tanzania, the percentage of people utilizing the private sector was found 
to increase during drug stock-outs in the public sector (34). Private sector expansion which allowed 
small scale, lower cost, and poorer quality facilities to grow in several sub-Saharan countries was 
linked to higher public sector user charges, as well as deregulation of private provision (2). 
Conversely, Sri Lanka and Thailand show how higher, well-targeted public spending can create a 
more accessible and better quality public sector, restricting opportunities for private sector 
involvement mainly to higher quality services for richer people (2). 
Public sector policies can also shape the space left for private sector provision. For example, in urban 
Mozambique, the presence of both reasonable drug availability in public hospitals and parastatal 
pharmacies for outpatients that reliably stock affordable essential medicines, directs private 
involvement in the market to upper income segments, signalling high quality with branded drugs, 
superior packaging, and significantly higher prices (35).  
The extent to which dual practice occurs within the public and private health sectors will influence 
the performance of each sector. Dual practice is a common feature of many LMIC health systems 
(36). While most health practitioners are trained in the public sector, many practitioners choose to 
either leave the public sector completely or supplement their income in the private sector (37). 
Evidence from studies of medical career paths indicates that doctors, and to a lesser extent nurses, 
move between the public and private sectors, influencing the performance of both sectors (37). Dual 
practice may lead to increased referral to the private sector, leading to increased patient costs, 
increased absenteeism in the public sector, suppression of quality of care in the public sector, 
increased capacity to retain health workers in the health system as a whole, but such potential 
impacts are themselves contingent on other health system features such as attempts at regulation 
and the extent of market opportunities (38-40).  
Characteristics of patients  
Patient characteristics also shape the performance of the private sector. Paucity of information 
available to patients on health care providers, lack of education, lack of economic capacity, and 
household and community preferences have been shown to act as barriers to the use of quality 
health services (41). Reducing these barriers enables patients to make better choices about their 
healthcare, and access higher quality health services in both the public and private sectors. While 
education itself has been found to be an important factor in determining overall health, higher levels 
of education have also been found to increase the desired and actual use of quality health services, 
inducing patients to move away from unqualified private providers towards qualified public or 
private services (42). There is evidence in Bangladesh, for example, that patients with some 
education are more likely than those with no education to switch to a qualified allopathic provider 
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from an unqualified provider (43). Similarly, patients describing themselves as impoverished are 
more likely to seek care from unqualified private providers.  
Although evidence is lacking, better economic conditions seem likely to spur an improvement in the 
quality of both public and private medical services. Increased purchasing power, concentrated in 
urban areas, for example, may allow hospitals to reach a size that allows them to provide improved 
quality of service through a more qualified and stable workforce and improved facilities. In some 
parts of India there is a trend to larger private hospitals; industry projections suggest a rapid growth 
in the size and specialisation of private hospitals over the next five years (44, 45). Larger size 
hospitals, resulting from an increase in patient demand, could provide the opportunity to reduce 
unit costs, but also, as suggested in the section above on the effects of size, lead to quality 
improvements.  
Regulation  
The purpose of regulation is to control provider behaviour and ensure that private providers offer 
services that not only are acceptable to the public, but also meet overall health sector goals (21, 46). 
Lack of regulation can lead to the growth and greater use of small scale, poorer-quality facilities, as 
was seen in Ghana, Malawi, Tanzania, and Zambia (2); or a high-quality private sector which 
becomes inaccessible to lower socio-economic groups due to the high cost or care, such as in South 
Africa and Argentina (2). Certification  ? a type of voluntary self-regulation which individual providers 
can obtain after meeting a set of standards  ? is one form of regulation which can help to ensure high 
levels of qualified and competent staff within private health facilities (20, 21). Likewise, accreditation 
 ? another type of voluntary self-regulation which health facilities can obtain after meeting a set of 
standards  ? may be effective in influencing the overall quality of private health facilities  (28). A 
review of the private sector in India, for example, highlighted a reduction in surgical infection rates 
following adoption of international accreditation standards (47). Private hospital accreditation in 
Thailand appears to have improved overall patient satisfaction and health outcomes, including 
inpatient mortality (48, 49).  
Despite these examples, evidence of effective regulation is rare and may be related to the context in 
which the sector is working. In Thailand, for example, a competitive network of private hospitals 
much utilised by medical tourists works alongside a strong well-funded public sector. Accreditation 
in India is largely restricted to large private hospitals that offer services to wealthy residents and 
patients from abroad, and there is little regulation of the smaller hospitals and clinics that dominate 
the sector. Governments in most low-income countries lack capacity to provide effective regulation, 
and there are few external influences (such as medical tourism) to induce change. Paper 3 within 
this series discusses regulation as a type of intervention in more detail (50). 
Discussion: Implications for Universal Health Coverage 
The policy objective of Universal Health Coverage suggests that rather than focus only on the 
productivity or quality of individual or a specific group of private providers, it is important to 
understand not only what factors influence overall health system performance, but how these 
factors interact. Understanding these interactions can then help to develop policy and interventions 
that focus on different parts of the private (and public) sector with the aim of improving overall 
sector performance and population health.  
Figure 1 proposes a set of relationships, moving from the micro level of individual providers and 
their characteristics which have been more extensively researched to their potential UHC 
implications. 
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Figure one: Factors affecting the performance of the private health sector 
What is sought from the perspective of progress towards UHC is a health system that maximises 
health outcomes, and equitably distributes feasible levels of good quality financially and 
geographically accessible services, that are delivered efficiently, with low levels of out-of-pocket 
burden, distributed progressively (according to affordability).  
The figure is informed by the literature reviewed above. Despite the lack of evidence regarding 
system-level factors, studies exploring individual private provider performance offer suggestions 
about system level influences and impacts. For example, evidence discussed above suggests that the 
structures of both the public and private sectors, the characteristics of patients, and the regulation 
of the sector all influence the types and outcomes of health services delivered. The contribution of 
the private sector better supports good outcomes in areas where users are wealthier and better 
informed, particularly in cities, where patients can demand higher quality services and choose to use 
only those services that they deem high quality. As a result, services are more likely to be delivered 
by qualified private providers who spend on average a longer amount of time with each patient, 
with improved outcomes for quality, equity, and efficiency, particularly for more complex diseases.  
Ensuring services are safe and effective requires standards that are enforced and monitored. Most 
experience of government bureaucratic regulation in low-income countries is rather negative, 
although other regulatory instruments may be more effective (50). Regulation will also have an 
influence on and be influenced by the structure of the sectors with regulation of qualified and 
unqualified providers implemented in different ways. A minimal regulatory response requires 
government to ensure that essential services are accessible both geographically and financially 
within the health sector as a whole, while at the same time protecting individuals from poor quality 
services. This suggests that changing private sector performance requires a regulatory response 
which not only targets private providers, but also the health sector as a whole. Influencing the 
quality, efficiency, and equity in access within the public sector is likely to lead to changes within the 
private sector over time for example. 
The achievement of good system level impacts is clearly frustrated by some characteristics of private 
provision discussed above. For example, inefficient provision of unnecessary interventions reduces 
quality, efficiency, and likely (by absorbing limited skilled professionals and occupying market space), 
the accessibility of any quality efficient provider, and increases the burden of out-of-pocket 
expenditure. Dual practice has been identified with a number of potential impacts  ? for example 
increased private sector referral and costs, as mentioned above, but considered from a system level, 
it may also retain health staff in the system as a whole, increasing the availability of qualified 
personnel to users of the public sector.  
Given the limited empirical evidence, the figure also inevitably draws on plausible, logical 
relationships, as well as empirically suggested ones. The lack of research and the difficulties of 
researching system level impacts explain why many arguments remain hypothetical. Empirical 
ŽƉƉŽƌƚƵŶŝƚŝĞƐƚŽƐƚƵĚǇƚŚĞ ‘ĐŽƵŶƚĞƌ-ĨĂĐƚƵĂů ? ?what the system would look like without private 
provision, without dual practice, or with a different regulatory environment for example, are not 
available. Such significant variation in health system character cannot be manipulated by policy 
experiment. Paper 4 in this series will return to this question by comparing countries in which such 
characteristics vary through using national level trends in characteristics and system impacts. 
Changing the performance of the private sector will require interventions which target the sector as 
a whole, not individual providers in isolation. Evidence focused on individual performance may 
mislead. Despite the difficulties, future research should look more critically at the way in which 
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system factors encourage the creation of a given mix of public and private services and how 
regulation and other policy instruments can be used to ensure a mix of services that promotes the 
system level efficiency, equity, and responsiveness that will support UHC. 
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